Yan-Bo Yang, Ph.D., President&CEO, BioPharmaDev, Inc.
Dr. Yan-Bo Yang has 30 years strong experiences in chemical analyses and purification of both small pharmaceutical compounds and large biologics; generic drug product developments; cGMP, regulations and compliances; and project management. Dr. Yang is an expert in chromatography theory, chromatography column technology and
MDr. Michael Ye is the R&D Manager of Liquid Separation Department in Supelco, a division of Sigma-Aldrich. He has over 20 years experience in chromatographic analysis and separation including over 10 years experience in separation product research and development. He received his bachelor's degree from the Department of Chemistry, Lanzhou University and Ph.D. from the Institute of Chemistry, Chinese Academy of Science, Beijing, China. He has a MBA degree from Colorado State University.
Dr. Tao Jiang is an expert in HPLC, GC and LC/MS with more than 20 years of research experience in separation media, instrumentation and their applications in pharmaceutical field. Currently she is a technical fellow in R&D at Mallinckrodt Pharmaceuticals. Dr. Jiang has published 23 papers, two book chapters, and 34 patents/patent applications; she has delivered more than 50 conference presentations. She received her M.S. in Organic
Dr. Chuping Luo is the Senior Research Scientist in Advanced Materials Technology. His interests includes developing new chromatographic stationary phases and application methods for bio-separation and small molecules.
From 2010 to 2015, Dr. Luo was the Principal Scientist in Waters Corporation, where he developed many critical methods in solving the applications in Supercritical Fluid Chromatography
Dr. Zhang received his B.S. from Lanzhou University, China and his M.S. from the Institute of Modern Physics, Chinese Academy of Sciences. He joined Purdue University in 1996, and worked in Dr. Fred E. Regnier’s laboratory. After receiving his Ph.D. degree in 2001, Dr. Zhang joined Beyond Genomics, Inc., a systems biology company in Boston, to develop bioanalytical and bioinformatics platforms for disease biomarker discovery and validation. In 2004, Dr. Zhang returned to Purdue University as the Director of